|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-3-3
|
|
pubmed:abstractText |
To improve radioimmunotherapy with anti-CD66 antibody, a physiologically based pharmacokinetic (PBPK) model was developed that was capable of describing the biodistribution and extrapolating between different doses of anti-CD66 antibody.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1535-5667
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
484-91
|
|
pubmed:meshHeading |
pubmed-meshheading:20150257-Adult,
pubmed-meshheading:20150257-Aged,
pubmed-meshheading:20150257-Antibodies,
pubmed-meshheading:20150257-Antigens, CD,
pubmed-meshheading:20150257-Cell Adhesion Molecules,
pubmed-meshheading:20150257-Female,
pubmed-meshheading:20150257-Humans,
pubmed-meshheading:20150257-Leukemia,
pubmed-meshheading:20150257-Male,
pubmed-meshheading:20150257-Middle Aged,
pubmed-meshheading:20150257-Models, Biological,
pubmed-meshheading:20150257-Radioimmunotherapy,
pubmed-meshheading:20150257-Reproducibility of Results,
pubmed-meshheading:20150257-Tissue Distribution,
pubmed-meshheading:20150257-Yttrium Radioisotopes
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Radioimmunotherapy with anti-CD66 antibody: improving the biodistribution using a physiologically based pharmacokinetic model.
|
|
pubmed:affiliation |
Klinik für Nuklearmedizin, Universität Ulm, Ulm, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
